点击图片查看原图
| P-0303 | Pancreatic Polypeptide (rat) | C195H298N58O57S | 4398.93 | 90419-12-8 | H-Ala-Pro-Leu-Glu-Pro-Met-Tyr-Pro-Gly-Asp-Tyr-Ala-Thr-His-Glu-Gln-Arg-Ala-Gln-Tyr-Glu-Thr-Gln-Leu-Arg-Arg-Tyr-Ile-Asn-Thr-Leu-Thr-Arg-Pro-Arg-Tyr-NH2 |
| P-0304 | Pancreatic Polypeptide (rana temporaria) | C192H276N52O58 | 4240.62 | 132187-74-7 | H-Ala-Pro-Ser-Glu-Pro-His-His-Pro-Gly-Asp-Gln-Ala-Thr-Gln-Asp-Gln-Leu-Ala-Gln-Tyr-Tyr-Ser-Asp-Leu-Tyr-Gln-Tyr-Ile-Thr-Phe-Val-Thr-Arg-Pro-Arg-Phe-NH2 |
| P-0305 | Pancreatic Polypeptide (31-36) (human) | C36H61N13O8 | 803.96 | 74012-13-8 | H-Leu-Thr-Arg-Pro-Arg-Tyr-NH2 |
| P-0306 | Pancreatic Polypeptide (31-36) (free acid) (human) | C36H60N12O9 | 804.95 | 192432-73-8 | H-Leu-Thr-Arg-Pro-Arg-Tyr-OH |
| P-0401 | PAR-1 (1-6) (mouse, rat) Thrombin Receptor (1-6) (mouse, rat), Proteinase Activated Receptor 1 (1-6) (mouse, rat), SFFLRN |
C37H54N10O9 | 782.90 | 140436-67-5 | H-Ser-Phe-Phe-Leu-Arg-Asn-OH |
| P-0402 | (Phe1,Ser2,Tyr6)-PAR-1 (1-6) amide (human) FSLLRYamide, (Phe1,Ser2,Tyr6)-Coagulation Factor II Receptor (1-6) amide (mouse), (Phe1,Ser2,Tyr6)-Proteinase Activated Receptor 1 (1-6) amide (human), (Phe1,Ser2,Tyr6)-Thrombin Receptor (1-6) amide (human) |
C39H60N10O8 | 796.97 | 245329-02-6 | H-Phe-Ser-Leu-Leu-Arg-Tyr-NH2 |
| P-0403 | PAR-2 (1-6) (human) Thrombin Receptor-Like 1 (1-6) (human), SLIGKV, Proteinase Activated Receptor 2 (1-6) (human), Coagulation Factor II Receptor-Like 1 (1-6) (human) |
C28H53N7O8 | 615.77 | 202933-49-1 | H-Ser-Leu-Ile-Gly-Lys-Val-OH |
| P-0404 | PAR-2 (1-6) (mouse, rat) Coagulation Factor II Receptor-Like 1 (1-6) (mouse, rat), Proteinase Activated Receptor 2 (1-6) (mouse, rat), SLIGRL, Thrombin Receptor-Like 1 (1-6) (mouse, rat) |
C29H55N9O8 | 657.81 | 164081-25-8 | H-Ser-Leu-Ile-Gly-Arg-Leu-OH |
| P-0403-2 | PAR-2 (1-6) amide (human) Thrombin Receptor-Like 1 (1-6) amide (human), SLIGKVamide, Proteinase Activated Receptor 2 (1-6) amide (human), Coagulation Factor II Receptor-Like 1 (1-6) amide (human) |
C28H54N8O7 | 614.79 | 190383-13-2 | H-Ser-Leu-Ile-Gly-Lys-Val-NH2 |
| P-0405 | PAR-2 (6-1) amide (human) retro-PAR-2 (1-6) amide (human), retro-SLIGKVamide, Thrombin Receptor-Like 1 (6-1) amide (human), Proteinase Activated Receptor 2 (6-1) amide (human), VKGILSamide, Coagulation Factor II Receptor-Like 1 (6-1) amide (human) |
C28H54N8O7 | 614.79 | 942413-05-0 | H-Val-Lys-Gly-Ile-Leu-Ser-NH2 |
| P-0404-2 | PAR-2 (1-6) amide (mouse, rat) Thrombin Receptor-Like 1 (1-6) amide (mouse, rat), SLIGRLamide, Proteinase Activated Receptor 2 (1-6) amide (mouse, rat), Coagulation Factor II Receptor-Like 1 (1-6) amide (mouse, rat) |
C29H56N10O7 | 656.83 | 171436-38-7 | H-Ser-Leu-Ile-Gly-Arg-Leu-NH2 |
| P-0406 | 2-(2-Furoyl)-PAR-2 (2-6)-Orn amide (mouse, rat) 2-(2-Furoyl)-LIGRLOamide |
C36H63N11O8 | 777.97 | 729589-58-6 | 2-(2-Furoyl)-Leu-Ile-Gly-Arg-Leu-Orn-NH2 |
| P-0407 | PAR-2 (6-1) amide (mouse, rat) LRGILSamide |
C29H56N10O7 | 656.83 | 245329-01-5 | H-Leu-Arg-Gly-Ile-Leu-Ser-NH2 |
| P-0408 | PAR-3 (1-6) (human) Coagulation Factor II Receptor-Like 2 (1-6) (human), Proteinase Activated Receptor 3 (1-6) (human), Thrombin Receptor-Like 2 (1-6) (human), TFRGAP |
C29H45N9O8 | 647.73 | 320347-28-2 | H-Thr-Phe-Arg-Gly-Ala-Pro-OH |
| P-0408-2 | PAR-3 (1-6) amide (human) Coagulation Factor II Receptor-Like 2 (1-6) amide (human), Thrombin Receptor-Like 2 (1-6) amide (human), Proteinase Activated Receptor 3 (1-6) amide (human), TFRGAPamide |
C29H46N10O7 | 646.75 | H-Thr-Phe-Arg-Gly-Ala-Pro-NH2 | |
| P-0409 | PAR-3 (1-6) amide (mouse) Proteinase Activated Receptor 3 (1-6) amide (mouse), SFNGGPamide, Thrombin Receptor-Like 2 (1-6) amide (mouse), Coagulation Factor II Receptor-Like 2 (1-6) amide (mouse) |
C25H36N8O8 | 576.61 | 261521-21-5 | H-Ser-Phe-Asn-Gly-Gly-Pro-NH2 |
| P-0410 | PAR-4 (1-6) (human) GYPGQV, Coagulation Factor II Receptor-Like 3 (1-6) (human), Proteinase Activated Receptor 4 (1-6) (human), Thrombin Receptor-Like 3 (1-6) (human) |
C28H41N7O9 | 619.68 | 225779-44-2 | H-Gly-Tyr-Pro-Gly-Gln-Val-OH |
| P-0411 | PAR-4 (1-6) (mouse) Thrombin Receptor-Like 3 (1-6) (mouse), Proteinase Activated Receptor 4 (1-6) (mouse), Coagulation Factor II Receptor-Like 3 (1-6) (mouse), GYPGKF |
C33H45N7O8 | 667.76 | 213018-42-9 | H-Gly-Tyr-Pro-Gly-Lys-Phe-OH |
| P-0411-2 | (Ala1)-PAR-4 (1-6) (mouse) (Ala1)-Thrombin Receptor-Like 3 (1-6) (mouse), (Ala1)-Proteinase Activated Receptor 4 (1-6) (mouse), (Ala1)-Coagulation Factor II Receptor-Like 3 (1-6) (mouse), AYPGKF |
C34H47N7O8 | 681.79 | 380900-00-5 | H-Ala-Tyr-Pro-Gly-Lys-Phe-OH |
| P-0410-2 | PAR-4 (1-6) amide (human) Thrombin Receptor-Like 3 (1-6) amide (human), Proteinase Activated Receptor 4 (1-6) amide (human), GYPGQVamide, Coagulation Factor II Receptor-Like 3 (1-6) amide (human) |
C28H42N8O8 | 618.69 | 245443-51-0 | H-Gly-Tyr-Pro-Gly-Gln-Val-NH2 |
| P-0411-3 | PAR-4 (1-6) amide (mouse) Coagulation Factor II Receptor-Like 3 (1-6) amide (mouse), GYPGKFamide, Proteinase Activated Receptor 4 (1-6) amide (mouse), Thrombin Receptor-Like 3 (1-6) amide (mouse) |
C33H46N8O7 | 666.78 | 245443-52-1 | H-Gly-Tyr-Pro-Gly-Lys-Phe-NH2 |
| P-0411-4 | (Ala1)-PAR-4 (1-6) amide (mouse) AYPGKFamide, (Ala1)-Thrombin Receptor-Like 3 (1-6) amide (mouse), (Ala1)-Coagulation Factor II Receptor-Like 3 (1-6) amide (mouse), (Ala1)-Proteinase Activated Receptor 4 (1-6) amide (mouse) |
C34H48N8O7 | 680.80 | 352017-71-1 | H-Ala-Tyr-Pro-Gly-Lys-Phe-NH2 |
| P-0412 | C25H38N6O6 | 518.61 | 74875-72-2 | Boc-D-Phe-Pro-Arg-OH | |
| P-0501 | Acetyl-Pepstatin | C31H57N5O9 | 643.82 | 28575-34-0 | Ac-Val-Val-Sta-Ala-Sta-OH |
| P-0502 | C39H65N5O9 | 747.97 | 98092-14-9 | Isovaleryl-Phe-Nle-Sta-Ala-Sta-OH | |
| P-0503 | C25H47N3O6 | 485.66 | 120849-36-7 | Isovaleryl-Val-Val-Sta-Oet | |
| P-0504 | Pepstatin A | C34H63N5O9 | 685.90 | 26305-03-3 | Isovaleryl-Val-Val-Sta-Ala-Sta-OH |
| P-0601 | (D-Ala1)-Peptide T | C35H55N9O16 | 857.87 | 106362-33-8 | H-D-Ala-Ser-Thr-Thr-Thr-Asn-Tyr-Thr-OH |
| P-0602 | (D-Ala1)-Peptide T amide DAPTA |
C35H56N10O15 | 856.89 | 106362-34-9 | H-D-Ala-Ser-Thr-Thr-Thr-Asn-Tyr-Thr-NH2 |
| P-0701 | Peptide YY (human), PYY (human) | C194H295N55O57 | 4309.81 | 118997-30-1 | H-Tyr-Pro-Ile-Lys-Pro-Glu-Ala-Pro-Gly-Glu-Asp-Ala-Ser-Pro-Glu-Glu-Leu-Asn-Arg-Tyr-Tyr-Ala-Ser-Leu-Arg-His-Tyr-Leu-Asn-Leu-Val-Thr-Arg-Gln-Arg-Tyr-NH2 |
| P-0701-2 | (Leu31,Pro34)-Peptide YY (human), (Leu31,Pro34)-PYY (human) | C195H296N54O56 | 4292.83 | 179986-95-9 | H-Tyr-Pro-Ile-Lys-Pro-Glu-Ala-Pro-Gly-Glu-Asp-Ala-Ser-Pro-Glu-Glu-Leu-Asn-Arg-Tyr-Tyr-Ala-Ser-Leu-Arg-His-Tyr-Leu-Asn-Leu-Leu-Thr-Arg-Pro-Arg-Tyr-NH2 |
| P-0701-3 | (Pro34)-Peptide YY (human), (Pro34)-PYY (human) | C194H294N54O56 | 4278.8 | 179986-93-7 | H-Tyr-Pro-Ile-Lys-Pro-Glu-Ala-Pro-Gly-Glu-Asp-Ala-Ser-Pro-Glu-Glu-Leu-Asn-Arg-Tyr-Tyr-Ala-Ser-Leu-Arg-His-Tyr-Leu-Asn-Leu-Val-Thr-Arg-Pro-Arg-Tyr-NH2 |
| P-0702 | Peptide YY (canine, mouse, porcine, rat), PYY (canine, mouse, porcine, rat) | C190H288N54O57 | 4240.71 | 81858-94-8 | H-Tyr-Pro-Ala-Lys-Pro-Glu-Ala-Pro-Gly-Glu-Asp-Ala-Ser-Pro-Glu-Glu-Leu-Ser-Arg-Tyr-Tyr-Ala-Ser-Leu-Arg-His-Tyr-Leu-Asn-Leu-Val-Thr-Arg-Gln-Arg-Tyr-NH2 |
| P-0703 | Peptide YY (3-36) (canine, mouse, porcine, rat), PYY (3-36) (canine, mouse, porcine, rat) | C176H272N52O54 | 3980.41 | 126339-09-1 | H-Ala-Lys-Pro-Glu-Ala-Pro-Gly-Glu-Asp-Ala-Ser-Pro-Glu-Glu-Leu-Ser-Arg-Tyr-Tyr-Ala-Ser-Leu-Arg-His-Tyr-Leu-Asn-Leu-Val-Thr-Arg-Gln-Arg-Tyr-NH2 |
| P-0704 | Peptide YY (3-36) (human), PYY (3-36) (human) | C180H279N53O54 | 4049.52 | 123583-37-9 | H-Ile-Lys-Pro-Glu-Ala-Pro-Gly-Glu-Asp-Ala-Ser-Pro-Glu-Glu-Leu-Asn-Arg-Tyr-Tyr-Ala-Ser-Leu-Arg-His-Tyr-Leu-Asn-Leu-Val-Thr-Arg-Gln-Arg-Tyr-NH2 |
| P-0705 | Peptide YY (13-36) (canine, mouse, porcine, rat), PYY (13-36) (canine, mouse, porcine, rat) | C135H209N41O38 | 3014.4 | 86895-09-2 | H-Ser-Pro-Glu-Glu-Leu-Ser-Arg-Tyr-Tyr-Ala-Ser-Leu-Arg-His-Tyr-Leu-Asn-Leu-Val-Thr-Arg-Gln-Arg-Tyr-NH2 |
| P-0801 | Physalaemin | C58H84N14O16S | 1265.46 | 2507-24-6 | Pyr-Ala-Asp-Pro-Asn-Lys-Phe-Tyr-Gly-Leu-Met-NH2 |
| P-0802 | H-Lys-Phe-Tyr-OH | C24H32N4O5 | 456.54 | 63958-93-0 | H-Lys-Phe-Tyr-OH |
| P-0803 | H-Phe-Tyr-OH | C18H20N2O4 | 328.37 | 17355-18-9 | H-Phe-Tyr-OH |
| P-0901 | C34H53N9O13 | 795.85 | Pyr-Val-Asp-Pro-Asn-Ile-Gln-OH | ||
| P-0902 | C37H58N10O14 | 866.93 | Pyr-Val-Asp-Pro-Asn-Ile-Gln-Ala-OH | ||
| P-1001 | PACAP Related Peptide (1-29) (rat), PRP (1-29) (rat) | C148H242N42O45S | 3361.87 | 132769-35-8 | H-Asp-Val-Ala-His-Glu-Ile-Leu-Asn-Glu-Ala-Tyr-Arg-Lys-Val-Leu-Asp-Gln-Leu-Ser-Ala-Arg-Lys-Tyr-Leu-Gln-Ser-Met-Val-Ala-OH |
| P-1002 | PACAP-27 (human, mouse, ovine, porcine, rat), Pituitary Adenylate Cyclase Activating Polypeptide-27 (human, mouse, ovine, porcine, rat), PACAP-38 (1-27) amide (human, mouse, ovine, porcine, rat) | C142H224N40O39S | 3147.65 | 127317-03-7 | H-His-Ser-Asp-Gly-Ile-Phe-Thr-Asp-Ser-Tyr-Ser-Arg-Tyr-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Ala-Ala-Val-Leu-NH2 |
| P-1003 | PACAP-27 (6-27) (human, chicken, mouse, ovine, porcine, rat), Pituitary Adenylate Cyclase Activating Polypeptide-27 (6-27) (human, chicken, mouse, ovine, porcine, rat) | C121H193N33O31S | 2638.13 | 136134-68-4 | H-Phe-Thr-Asp-Ser-Tyr-Ser-Arg-Tyr-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Ala-Ala-Val-Leu-NH2 |
| P-1004 | PACAP-38 (human, mouse, ovine, porcine, rat), Pituitary Adenylate Cyclase Activating Polypeptide-38 (human, mouse, ovine, porcine, rat) | C203H331N63O53S | 4534.32 | 124123-15-5 | H-His-Ser-Asp-Gly-Ile-Phe-Thr-Asp-Ser-Tyr-Ser-Arg-Tyr-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Ala-Ala-Val-Leu-Gly-Lys-Arg-Tyr-Lys-Gln-Arg-Val-Lys-Asn-Lys-NH2 |
| P-1004-2 | Acetyl-PACAP-38 (human, mouse, ovine, porcine, rat), Acetyl-Pituitary Adenylate Cyclase Activating Polypeptide-38 (human, mouse, ovine, porcine, rat) | C205H333N63O54S | 4576.36 | 156106-32-0 | Ac-His-Ser-Asp-Gly-Ile-Phe-Thr-Asp-Ser-Tyr-Ser-Arg-Tyr-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Ala-Ala-Val-Leu-Gly-Lys-Arg-Tyr-Lys-Gln-Arg-Val-Lys-Asn-Lys-NH2 |
| P-1005 | PACAP-38 (6-38) (human, chicken, mouse, ovine, porcine, rat), Pituitary Adenylate Cyclase Activating Polypeptide-38 (6-38) (human, chicken, mouse, ovine, porcine, rat) | C182H300N56O45S | 4024.8 | 143748-18-9 | H-Phe-Thr-Asp-Ser-Tyr-Ser-Arg-Tyr-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Ala-Ala-Val-Leu-Gly-Lys-Arg-Tyr-Lys-Gln-Arg-Val-Lys-Asn-Lys-NH2 |
| P-1006 | PACAP-38 (16-38) (human, chicken, mouse, ovine, porcine, rat), Pituitary Adenylate Cyclase Activating Polypeptide-38 (16-38) (human, chicken, mouse, ovine, porcine, rat) | C123H215N39O28S | 2720.37 | 144025-82-1 | H-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Ala-Ala-Val-Leu-Gly-Lys-Arg-Tyr-Lys-Gln-Arg-Val-Lys-Asn-Lys-NH2 |
| P-1007 | PACAP-38 (28-38) (human, chicken, mouse, ovine, porcine, rat), Pituitary Adenylate Cyclase Activating Polypeptide-38 (28-38) (human, chicken, mouse, ovine, porcine, rat) | C61H110N24O14 | 1403.7 | 160489-86-1 | H-Gly-Lys-Arg-Tyr-Lys-Gln-Arg-Val-Lys-Asn-Lys-NH2 |
| P-1008 | PACAP-38 (31-38) (human, chicken, mouse, ovine, porcine, rat), Pituitary Adenylate Cyclase Activating Polypeptide-38 (31-38) (human, chicken, mouse, ovine, porcine, rat) | C47H83N17O11 | 1062.28 | 138764-85-9 | H-Tyr-Lys-Gln-Arg-Val-Lys-Asn-Lys-NH2 |
| P-1101 | Tyr-PDGF A-Chain (194-211) | C101H181N39O25 | 2341.8 | 137132-69-5 | H-Tyr-Gly-Arg-Pro-Arg-Glu-Ser-Gly-Lys-Lys-Arg-Lys-Arg-Lys-Arg-Leu-Lys-Pro-Thr-OH |
| P-1102 | PDGF Antagonist | C77H122N20O17 | 1599.94 | 143784-00-3 | H-Ala-Asn-Phe-Leu-Val-Trp-Glu-Ile-Val-Arg-Lys-Lys-Pro-OH |
| P-1103 | PDGF β-Receptor (719-723) (phosphorylated) | C30H48N5O10SP | 701.78 | H-Tyr(PO3H2)-Val-Pro-Met-Leu-OH | |
| P-1104 | PDGF β-Receptor (739-746) (phosphorylated) | C48H62N9O18SP | 1116.11 | H-Tyr(PO3H2)-Met-Ala-Pro-Tyr-Asp-Asn-Tyr-OH | |
| P-1201 | (Gln18)-Platelet Factor 4 (15-22) (human), (Gln18)-PF4 (15-22) (human), CT-112 | C38H69N15O13 | 944.06 | 144207-60-3 | H-Thr-Thr-Ser-Gln-Val-Arg-Pro-Arg-OH |
| P-1202 | Platelet Factor 4 (58-70) (human), PF4 (58-70) (human) | C76H133N17O18 | 1573.01 | 82989-21-7 | H-Pro-Leu-Tyr-Lys-Lys-Ile-Ile-Lys-Lys-Leu-Leu-Glu-Ser-OH |
| P-1301 | Pneumadin (human) | C41H70N12O14 | 955.08 | 130918-91-1 | H-Ala-Gly-Glu-Pro-Lys-Leu-Asp-Ala-Gly-Val-NH2 |
| P-1302 | Pneumadin (rat) | C47H74N12O15 | 1047.18 | 130918-90-0 | H-Tyr-Gly-Glu-Pro-Lys-Leu-Asp-Ala-Gly-Val-NH2 |
| P-1401 | (Tyr5·12,Lys7)-Polyphemusin II, T22 | C109H164N38O22S4 | 2487.01 | 147658-54-6 | H-Arg-Arg-Trp-Cys-Tyr-Arg-Lys-Cys-Tyr-Lys-Gly-Tyr-Cys-Tyr-Arg-Lys-Cys-Arg-NH2 (Disulfide bonds between Cys and Cys¹/Cys and Cys¹³) |
| P-1402 | Polyphemusin II-Derived Peptide, T140 | C90H141N33O18S2 | 2037.45 | 229030-20-0 | H-Arg-Arg-2-Nal-Cys-Tyr-Arg-Lys-D-Lys-Pro-Tyr-Arg-Cit-Cys-Arg-OH (Disulfide bond) |
| P-1501 | Preptin (human) | C187H275N47O53 | 4029.53 | 315197-69-4 | H-Asp-Val-Ser-Thr-Pro-Pro-Thr-Val-Leu-Pro-Asp-Asn-Phe-Pro-Arg-Tyr-Pro-Val-Gly-Lys-Phe-Phe-Gln-Tyr-Asp-Thr-Trp-Lys-Gln-Ser-Thr-Gln-Arg-Leu-OH |
| P-1502 | Preptin (rat) | C181H268N48O51 | 3932.41 | 315197-73-0 | H-Asp-Val-Ser-Thr-Ser-Gln-Ala-Val-Leu-Pro-Asp-Asp-Phe-Pro-Arg-Tyr-Pro-Val-Gly-Lys-Phe-Phe-Lys-Phe-Asp-Thr-Trp-Arg-Gln-Ser-Ala-Gly-Arg-Leu-OH |
| P-1601-2 | Boc-Pressinoic acid | C38H50N8O12S2 | 874.99 | 72287-67-3 | Boc-Cys-Tyr-Phe-Gln-Asn-Cys-OH (Disulfide bond) |
| P-1601 | Pressinoic acid | C33H42N8O10S2 | 774.88 | 35748-51-7 | H-Cys-Tyr-Phe-Gln-Asn-Cys-OH (Disulfide bond) |
| P-1601-3 | (Ile3)-Pressinoic acid, Tocinoic acid | C30H44N8O10S2 | 740.86 | 34330-23-9 | H-Cys-Tyr-Ile-Gln-Asn-Cys-OH (Disulfide bond) |
| P-1701 | Prion Protein (106-126) (human) | C80H138N26O24S2 | 1912.27 | 148439-49-0 | H-Lys-Thr-Asn-Met-Lys-His-Met-Ala-Gly-Ala-Ala-Ala-Ala-Gly-Ala-Val-Val-Gly-Gly-Leu-Gly-OH |
| P-1702 | Biotinyl-Prion Protein (106-126) (human) | C90H152N28O26S3 | 2138.57 | Biotinyl-Lys-Thr-Asn-Met-Lys-His-Met-Ala-Gly-Ala-Ala-Ala-Ala-Gly-Ala-Val-Val-Gly-Gly-Leu-Gly-OH | |
| P-1703 | Prion Protein (106-126) (human) (scrambled) | C80H138N26O24S2 | 1912.27 | 150469-23-1 | H-Asn-Gly-Ala-Lys-Ala-Leu-Met-Gly-Gly-His-Gly-Ala-Thr-Lys-Val-Met-Val-Gly-Ala-Ala-Ala-OH |
| P-1704 | Prion Protein (118-135) (human) | C68H112N18O22S2 | 1597.88 | 202121-03-7 | H-Ala-Gly-Ala-Val-Val-Gly-Gly-Leu-Gly-Gly-Tyr-Met-Leu-Gly-Ser-Ala-Met-Ser-OH |
| P-1705 | β-Sheet Breaker Peptide | C51H81N13O16 | 1132.28 | 339990-32-8 | H-Asp-Ala-Pro-Ala-Ala-Pro-Ala-Gly-Pro-Ala-Val-Pro-Val-OH |
| P-1801 | Procathepsin B (26-50) (rat) | C123H198N34O33S | 2713.2 | 317331-27-4 | H-Ala-Gly-Arg-Asn-Phe-Tyr-Asn-Val-Asp-Ile-Ser-Tyr-Leu-Lys-Lys-Leu-Cys-Gly-Thr-Val-Leu-Gly-Gly-Pro-Lys-NH2 |
| P-1802 | Procathepsin B (36-50) (rat) | C71H123N19O18S | 1562.94 | 317331-26-3 | H-Ser-Tyr-Leu-Lys-Lys-Leu-Cys-Gly-Thr-Val-Leu-Gly-Gly-Pro-Lys-NH2 |
| P-1901 | Procollagen Type I (212-216) | C23H45N7O9 | 563.65 | 149128-48-3 | H-Lys-Thr-Thr-Lys-Ser-OH |
| P-1902 | Procollagen α1 (1187-1218) (human) | C158H223N43O45 | 3444.77 | H-Gly-Pro-Pro-Gly-Pro-Pro-Ser-Ala-Gly-Phe-Asp-Phe-Ser-Phe-Leu-Pro-Gln-Pro-Pro-Gln-Glu-Lys-Ala-His-Asp-Gly-Gly-Arg-Tyr-Tyr-Arg-Ala-OH | |
| P-2001 | Prolactin-Releasing Peptide (1-31) (bovine), PrRP31 (bovine), Preprolactin (23-53) (bovine) | C157H244N54O41S | 3576.07 | H-Ser-Arg-Ala-His-Gln-His-Ser-Met-Glu-Ile-Arg-Thr-Pro-Asp-Ile-Asn-Pro-Ala-Trp-Tyr-Ala-Gly-Arg-Gly-Ile-Arg-Pro-Val-Gly-Arg-Phe-NH2 | |
| P-2002 | Prolactin-Releasing Peptide (1-31) (human), PrRP31 (human), Preprolactin (23-53) (human) | C160H252N56O42S | 3664.18 | 215510-22-8 | H-Ser-Arg-Thr-His-Arg-His-Ser-Met-Glu-Ile-Arg-Thr-Pro-Asp-Ile-Asn-Pro-Ala-Trp-Tyr-Ala-Ser-Arg-Gly-Ile-Arg-Pro-Val-Gly-Arg-Phe-NH2 |
| P-2003 | Prolactin-Releasing Peptide (1-31) (rat), PrRP31 (rat), Preprolactin (23-53) (rat) | C156H242N54O43S | 3594.04 | 215510-06-8 | H-Ser-Arg-Ala-His-Gln-His-Ser-Met-Glu-Thr-Arg-Thr-Pro-Asp-Ile-Asn-Pro-Ala-Trp-Tyr-Thr-Gly-Arg-Gly-Ile-Arg-Pro-Val-Gly-Arg-Phe-NH2 |
| P-2004 | Prolactin-Releasing Peptide (12-31) (bovine), PrRP20 (bovine), Preprolactin (34-53) (bovine) | C103H156N32O25 | 2242.57 | H-Thr-Pro-Asp-Ile-Asn-Pro-Ala-Trp-Tyr-Ala-Gly-Arg-Gly-Ile-Arg-Pro-Val-Gly-Arg-Phe-NH2 | |
| P-2005 | Prolactin-Releasing Peptide (12-31) (human), PrRP20 (human), Preprolactin (34-53) (human) | C104H158N32O26 | 2272.6 | 235433-36-0 | H-Thr-Pro-Asp-Ile-Asn-Pro-Ala-Trp-Tyr-Ala-Ser-Arg-Gly-Ile-Arg-Pro-Val-Gly-Arg-Phe-NH2 |
| P-2006 | Prolactin-Releasing Peptide (12-31) (rat), PrRP20 (rat), Preprolactin (34-53) (rat) | C104H158N32O26 | 2272.6 | 222988-10-5 | H-Thr-Pro-Asp-Ile-Asn-Pro-Ala-Trp-Tyr-Thr-Gly-Arg-Gly-Ile-Arg-Pro-Val-Gly-Arg-Phe-NH2 |
| P-2101 | C33H44N6O9 | 668.75 | 168781-78-0 | Ac-Ile-Tyr-Gly-Glu-Phe-NH2 | |
| P-2102 | C33H45N6O12P | 748.73 | 284660-72-6 | Ac-Ile-Tyr(PO3H2)-Gly-Glu-Phe-NH2 | |
| P-2103 | C47H74N10O10 | 939.17 | 300584-92-3 | Ac-Leu-Lys-Phe-Ser-Lys-Lys-Phe-OH | |
| P-2104 | C32H46N5O17P | 803.71 | 159439-02-8 | Ac-Tyr(PO3H2)-Glu-Glu-Ile-Glu-OH | |
| P-2105 | CSH 103 | C106H172N32O32 | 2406.73 | 135546-44-0 | H-Ala-Asp-Ala-Gln-His-Ala-Thr-Pro-Pro-Lys-Lys-Lys-Arg-Lys-Val-Glu-Asp-Pro-Lys-Asp-Phe-OH |
| P-2106 | (Ala92)-Peptide 6, (Ala92)-p16 (84-103) | C93H155N31O26 | 2123.45 | 189064-08-2 | H-Asp-Ala-Ala-Arg-Glu-Gly-Phe-Leu-Ala-Thr-Leu-Val-Val-Leu-His-Arg-Ala-Gly-Ala-Arg-OH |
| P-2107 | C39H70N18O11 | 967.1 | 138028-00-9 | H-Ala-Pro-Arg-Thr-Pro-Gly-Gly-Arg-Arg-OH | |
| P-2108 | C64H106N22O21 | 1519.68 | 81156-93-6 | H-Arg-Arg-Leu-Ile-Glu-Asp-Ala-Glu-Tyr-Ala-Ala-Arg-Gly-OH | |
| P-2109 | C66H109N23O23 | 1592.73 | 81493-98-3 | H-Arg-Arg-Leu-Ile-Glu-Asp-Asn-Glu-Tyr-Thr-Ala-Arg-Gly-OH | |
| P-2110 | C28H45N9O8 | 635.72 | 59587-24-5 | H-Arg-Gly-Tyr-Ala-Leu-Gly-OH |
